Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Pulmonary Disease

Answer 5
  1. IV alteplase 100 mg over 2 hours. This patient has developed shock related to PE, and thrombolytic therapy, such as alteplase, is often recommended in the absence of known contraindications. There is insufficient evidence to recommend any specific thrombolytic therapy over another. Dopamine is a vasoconstricting agent that may help to augment mean arterial blood pressure, but it does not offer an advantage over norepinephrine, which this patient is already receiving. Tirofiban is an antiplatelet glycoprotein IIb/IIIa inhibitor indicated in the treatment of acute coronary syndrome; it has no role in treating venous thromboembolic disease. Warfarin and argatroban are acceptable alternatives to heparin for treating thromboembolic disease but are no more effective than heparin and are not indicated for massive PE.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 7/6/07 • kkj